Jennifer Taubert - Johnson Johnson Chairman
JNJ Stock | ARS 11,500 25.00 0.22% |
Chairman
Ms. Jennifer L Taubert is the Executive Vice President Worldwide Chairman, Pharmaceuticals of the Company. She has joined the Company in 2005 as Worldwide Vice President at Johnson Johnson Pharmaceutical Services, a subsidiary of the Company. She held several executive positions in the Pharmaceutical sector until 2012 when she was appointed Company Group Chairman, North America Pharmaceuticals, and in 2015 became Company Group Chairman, The Americas, Pharmaceuticals. In July 2018, Ms. Taubert was promoted to Executive Vice President, Worldwide Chairman, Pharmaceuticals, and became a member of the Executive Committee. since 2018.
Age | 59 |
Tenure | 6 years |
Phone | 732 524 0400 |
Web | https://www.jnj.com |
Johnson Johnson Management Efficiency
The company has return on total asset (ROA) of 0.0881 % which means that it generated a profit of $0.0881 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2414 %, meaning that it generated $0.2414 on every $100 dollars invested by stockholders. Johnson Johnson's management efficiency ratios could be used to measure how well Johnson Johnson manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Found 11 records | CHAIRMAN Age | ||
Eduardo Elsztain | IRSA Propiedades Comerciales | 63 | |
Raul Rodriguez | Metrogas SA | N/A | |
Patricio Re | Metrogas SA | N/A | |
Juan Vivanco | Molinos Agro SA | N/A | |
Robert JD | Merck Company | 56 | |
Alejandro Elsztain | IRSA Propiedades Comerciales | 57 | |
Luis Companc | Molinos Agro SA | N/A | |
Dante Kogan | Metrogas SA | N/A | |
Kenneth Frazier | Merck Company | 67 | |
Eduardo Baldi | Metrogas SA | N/A | |
Fernando Ambroa | Metrogas SA | N/A |
Management Performance
Return On Equity | 0.24 | |||
Return On Asset | 0.0881 |
Johnson Johnson Leadership Team
Elected by the shareholders, the Johnson Johnson's board of directors comprises two types of representatives: Johnson Johnson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Johnson. The board's role is to monitor Johnson Johnson's management team and ensure that shareholders' interests are well served. Johnson Johnson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Johnson Johnson's outside directors are responsible for providing unbiased perspectives on the board's policies.
Dirk Brinckman, Chief Officer | ||
Robert Decker, Controller Officer | ||
Alex Gorsky, Chairman, CEO, Chairman of Executive Committee and Chairman of Fin. Committee | ||
Jessica Moore, VP Relations | ||
Joaquin Duato, Executive Vice President Worldwide Chairman - Pharmaceuticals | ||
Joseph CPA, Ex CFO | ||
James Swanson, Ex Officer | ||
Elizabeth Forminard, Exec Counsel | ||
Jennifer Taubert, Executive Vice President - Worldwide Chairman, Pharmaceuticals | ||
Peter Fasolo, Vice President - Global Human Resources |
Johnson Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Johnson Johnson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.24 | |||
Return On Asset | 0.0881 | |||
Profit Margin | 0.19 % | |||
Operating Margin | 0.27 % | |||
Current Valuation | 80.39 T | |||
Shares Outstanding | 13.07 B | |||
Price To Earning | 190.25 X | |||
Price To Book | 4.08 X | |||
Price To Sales | 831.09 X | |||
Revenue | 94.94 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Johnson Stock
Johnson Johnson financial ratios help investors to determine whether Johnson Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Johnson with respect to the benefits of owning Johnson Johnson security.